SAREPTA THERAPEUTICS INC - NOTE 1.250% 9/1

Historical Portfolio Holders from Q3 2023 to Q3 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Debt / NOTE 1.250% 9/1
Principal, excl. options Q2 2024
929M
Holdings value Q2 2024
$1.24B
Value change Q2 2024
-$102M
Grand Portfolio weight change Q2 2024
0%
Number of holders
73
Number of buys Q2 2024
36
Number of sells Q2 2024
-33
Average buys Q2 2024 %
+0.001%
Average sells Q2 2024 %
-0.001%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Principal Value Change Price Investors
2024 Q3 $800K $34.2M -$655K $1.13 3
2024 Q2 $929M $1.24B -$102M $1.29 73
2024 Q1 $1.01B $1.18B -$16M $1.17 61
2023 Q4 $1.04B $1.06B +$76.4M $1.01 63
2023 Q3 $955M $1.08B +$1.08B $1.12 62